Polymyositis and dermatomyositis as a risk of developing cancer.

about

Malignancy dominated with rheumatic manifestations: A retrospective single-center analysis.Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.

P2860

Q49595577-3F82AEB1-FEAE-4052-90E3-A90E173C5B00 Q53709840-36178A9F-001C-41D0-B722-913697922FC8

P2860

Polymyositis and dermatomyositis as a risk of developing cancer.

Item

http://www.wikidata.org/entity/Q36842357

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Polymyositis and dermatomyositis as a risk of developing cancer.

@en

type

Item

label

Polymyositis and dermatomyositis as a risk of developing cancer.

@en

prefLabel

Polymyositis and dermatomyositis as a risk of developing cancer.

@en

P1476

Polymyositis and dermatomyositis as a risk of developing cancer.

@en

P2093

Brygida Kwiatkowska

http://www.w3.org/2001/XMLSchema#string

Maria Maślińska

http://www.w3.org/2001/XMLSchema#string

Michał Jakubaszek

http://www.w3.org/2001/XMLSchema#string

P2860

Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease.

Prognostic factors for myositis-associated interstitial lung disease

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis

Dermatomyositis and malignancy: a retrospective study of 115 cases.

Positron Emission Tomography (PET) in Oncology

Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells.

P304

101-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/REUM.2015.51510

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276921162

http://www.w3.org/2001/XMLSchema#string

P698

27407235

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis

polymyositis

P932

4847280

http://www.w3.org/2001/XMLSchema#string

Polymyositis and dermatomyositis as a risk of developing cancer.

about

P2860

P2860

Polymyositis and dermatomyositis as a risk of developing cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932